PeterLabs Holdings Berhad (KLSE:PLABS)
Malaysia · Delayed Price · Currency is MYR 0.2700
0.00 (0.00%)
At close: Jan 23, 2026
PeterLabs Holdings Berhad Revenue
PeterLabs Holdings Berhad had revenue of 32.76M MYR in the quarter ending September 30, 2025, a decrease of -21.22%. This brings the company's revenue in the last twelve months to 152.65M, down -15.98% year-over-year. In the fiscal year ending June 30, 2025, PeterLabs Holdings Berhad had annual revenue of 161.47M, down -8.27%.
Revenue (ttm)
152.65M
Revenue Growth
-15.98%
P/S Ratio
0.49
Revenue / Employee
n/a
Employees
n/a
Market Cap
74.31M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 161.47M | -14.56M | -8.27% |
| Dec 31, 2024 | 176.03M | -10.18M | -5.47% |
| Dec 31, 2023 | 186.21M | 24.58M | 15.20% |
| Dec 31, 2022 | 161.63M | -22.19M | -12.07% |
| Dec 31, 2021 | 183.82M | 103.80M | 129.71% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| DXN Holdings Bhd. | 1.93B |
| Apex Healthcare Berhad | 970.14M |
| Duopharma Biotech Berhad | 900.68M |
| Y.S.P. Southeast Asia Holding Berhad | 367.14M |
| Kotra Industries Berhad | 223.64M |
| Rhone Ma Holdings Berhad | 211.93M |
| Sunzen Group Berhad | 77.29M |
| Nova Wellness Group Berhad | 45.99M |